Form 4: Alignment Healthcare Executive Sells Shares to Cover Tax Obligations After PSU Vesting

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, sold 55,403 shares to cover tax obligations following the vesting of performance share units (PSUs).

Summary

• Robert L. Scavo, the Chief Information Officer of Alignment Healthcare, acquired 292,000 shares of common stock on March 4, 2025, upon the vesting of performance share units (PSUs).
• The PSUs were granted on September 14, 2023, and vested based on the achievement of certain performance objectives related to health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA less capital expenditures.
• The performance objectives were achieved above target.
• 50% of the granted PSUs vested on March 4, 2025, and the remaining 50% will vest on December 31, 2025, contingent upon continued service.
• On March 6, 2025, Scavo sold 55,403 shares at a weighted-average price of $15.53 to cover tax withholding obligations related to the PSU vesting.
• The sales price ranged from $15.12 to $16.065 per share.
• Following the reported transactions, Scavo beneficially owns 673,419 shares of Alignment Healthcare.

Sentiment

Score: 6

Explanation: Neutral sentiment. The PSU vesting indicates positive performance, but the subsequent sale of shares, even for tax purposes, introduces a slightly negative element.

Positives

• The vesting of PSUs indicates that Alignment Healthcare achieved its performance objectives above target.
• The vesting of the PSUs is tied to health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA, less capital expenditures.

Negatives

• The sale of shares by the Chief Information Officer, even for tax obligations, could be perceived negatively by some investors.

Risks

• Future performance may not meet the targets required for the remaining 50% of the PSUs to vest on December 31, 2025.
• The sale of shares by insiders could create short-term price volatility.

Future Outlook

50% of the granted PSUs will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Industry Context

Executive compensation and insider trading activity are closely watched in the healthcare industry to gauge management's confidence in the company's future performance.

Comparison to Industry Standards

• PSU vesting based on revenue growth and profitability metrics is a common practice in the healthcare industry.
• Companies like UnitedHealth Group (UNH) and Humana (HUM) also use similar performance-based equity compensation plans for their executives.
• The specific targets for revenue growth and medical benefit ratio would need to be compared to industry benchmarks to assess the difficulty of achieving the PSU vesting requirements.

Stakeholder Impact

• Shareholders may be concerned about the sale of shares by an executive, even if for tax purposes.
• Employees may view the PSU vesting as a positive sign of the company's performance.

Next Steps

• Remaining 50% of PSUs to vest on December 31, 2025, contingent upon continued service.

Key Dates